Summary In 1983, we reported results from the Oxford Family Planning Association contraceptive study regarding the association between oral contraceptives (OCs) and cervical neoplasia, after a 10 year follow-up of a cohort of 17 000 women. Further findings from this study are reported here after an additional 12 years of follow-up. A nested case-control design was used in which cases were all women diagnosed under 45 years of age with invasive carcinoma (n = 33), carcinoma in situ (n = 121) or dysplasia (n = 159). Controls were randomly selected from among cohort members and matched to cases on exact year of birth and clinic attended at recruitment to study. Conditional logistic regression analysis was used to determine odds ratios (ORs) and 95% confidence intervals (CIs) associated with various aspects of OC use relative to never users adjusted for social class, smoking, age at first birth and ever use of diaphragm or condom. al., 1983). At that time, 13 cases of invasive cancer of the cervix had occurred during the 65 101 woman-years of follow-up for women who had entered the study as OC users, but no cases were found during the 26 432 womanyears of follow-up for those who had entered the study as intra-uterine device (IUD) users. Both carcinoma in situ and dysplasia also occurred more frequently among OC users than among IUD users (with relative risks of 1.60 and 1.45 respectively) and there was a statistically significant increasing trend in incidence of all cervical neoplasia combined with increasing duration of OC use (P<0.05).
In 1983, we described the association between carcinoma of the cervix and use of oral contraceptives (OCs) in a cohort of 17 000 women [the Oxford Family Planning Association (FPA) contraceptive study] after a 10 year follow-up period (Vessey et al., 1983) . At that time, 13 cases of invasive cancer of the cervix had occurred during the 65 101 woman-years of follow-up for women who had entered the study as OC users, but no cases were found during the 26 432 womanyears of follow-up for those who had entered the study as intra-uterine device (IUD) users. Both carcinoma in situ and dysplasia also occurred more frequently among OC users than among IUD users (with relative risks of 1.60 and 1.45 respectively) and there was a statistically significant increasing trend in incidence of all cervical neoplasia combined with increasing duration of OC use (P<0.05).
The previous analyses were based on relatively small numbers of events (a total of 136 cases for all cervical neoplasia combined). In the subsequent 12 years, a further 321 cases of cervical neoplasia have accrued, resulting in a total of 457 cases. We report here the association between oral contraceptive use (and use of other methods of contraception) and cervical neoplasia in 310 cases diagnosed under 45 years of age and 3091 matched controls identified from cohort members.
Materials and methods
A detailed description of the Oxford FPA study has been given elsewhere (Vessey et al., 1976) . In brief, 17 032 women were recruited at 17 large family planning clinics in England and Scotland between 1968 and 1974 . At the time of recruitment, each woman had to be: (1) aged 25-39 years, (2) married, (3) white and British, (4) willing to cooperate and (5) either a current user of OCs for at least 5 months or a current user of a diaphragm or an IUD for at least 5 months without previous exposure to OCs. Information collected at entry to the study included date of birth, age at marriage, social class of husband, smoking habits, weight and height, contraceptive history and obstetric and medical history.
During the annual clinic follow-up of each woman, information was recorded by a doctor or nurse about pregnancies and their outcome, changes in contraceptive practice, referrals to hospital and the frequency and outcome of cervical cytological examinations carried out at the clinic. Diagnoses on discharge from hospital were confirmed by obtaining copies of discharge letters, summaries and pathology reports. Women who stopped attending the clinic were sent a postal questionnaire annually, or, if this was not returned, were interviewed by telephone or during a home visit. The work was coordinated by a research assistant in each clinic. Loss to follow-up because women were untraced or refused to continue to cooperate was about 0.4% per annum.
In the nested case-control study reported here, cases were all women aged under 45 years who were diagnosed during follow-up as having histologically proven invasive cervical carcinoma (ICD 8th Revision 180.0), carcinoma in situ (ICD 8th Revision 234.0) or dysplasia (ICD 8th Revision 621.9, modified for the Oxford FPA study). We used the old nomenclature to describe the different types of non-invasive cervical neoplasia because many of the data were collected before the term 'cervical intraepithelial neoplasia' was widely used. Of the 326 cases potentially eligible for inclusion in the analysis, 16 were excluded because age at first birth was not known, leaving a total of 310 cases. Three cases were diagnosed on two separate occasions as having different types of cervical neoplasia: one with dysplasia followed by carcinoma in situ, the other two with carcinoma in situ followed by dysplasia. These women were included as cases in both diagnostic groups when analysed separately but, in analyses of all cervical neoplasia combined, data for the first diagnosis only were included.
For each case, up (before 1968, 1968 -1969 and 1970 or later) .
Data on a number of potential confounding variables (social class of husband, current cigarette smoking and age at first marriage) were obtained only at entry to the study, whereas information about induced abortion and miscarriage was collected only during follow-up; data about age at first birth and parity were collected both at entry and during follow-up. For 
Statistical analysis
Conditional logistic regression analysis (Breslow and Day, 1980) was used to obtain maximum likelihood estimates of odds ratios (ORs) for the various comparisons, with adjustment for social class, smoking and age at first birth because these variables are recognised as well-established risk factors for cervical neoplasia (Swan and Petitti, 1982; Greenberg et al., 1985) . ORs according to contraceptive method were calculated relative to never users with additional adjustment for ever use of OCs, diaphragm or condom (as appropriate) since associations between these three contraceptive methods and cervical neoplasia are also well established (Swan and Petitti, 1982) . Confidence intervals (95% CIs) were derived from the standard errors for model coefficients and checked using likelihood-based estimation; because of the small numbers of invasive cancers, however, all 95% confidence intervals for this group were likelihood based. Approximate chi-square statistics for trend or differences in ORs across categories were derived from likelihood-ratio test statistics. Tests for trend in ORs with increasing level of OC use (e.g. duration of use) were calculated with inclusion in the baseline logistic regression model of a term to represent never/ever use of OCs. Logistic regression analyses were performed using the statistical packages EPICURE (Hirosoft International Corporation, 1990) and EGRET (Statistics and Epidemiological Research Corporation, 1989 After adjustment for age at first birth, smoking and social class, women who were diaphragm users at entry to the study had a significantly lower risk of all cervical neoplasia combined than OC users (OR=0.48, 95% CI 0.32-0.72) but little difference was observed between women who were IUD users and OC users at entry to study (OR = 0.98, 95% CI 0.71-1.37) (results not shown). Ever users of OCs had a slightly higher overall risk of cervical neoplasia compared with never users (OR=1.62, 95% CI 1.19-2.22) but when additional adjustment was made for ever use of diaphragm or condom, the overall OR was reduced to 1.40 (Table II) . Within diagnostic groups the corresponding ORs were highest for invasive cancer (OR = 4.44), intermediate for carcinoma in situ (OR = 1.73) and lowest for dysplasia (OR = 1.07). Ever use of an IUD also appeared to be associated with a slightly increased overall risk of cervical neoplasia (OR= 1.38) and of invasive cancer in particular (OR= 4.49) .
Ever use of the diaphragm was associated with a lower risk for all cervical neoplasia combined (OR = 0.62), and this reduced risk was evident in the three diagnostic subgroups. Vasectomy was also associated with a lower risk overall, but here the effect appeared strongest for invasive cancer (OR = 0.17). Tubal sterilisation was associated with a significantly reduced risk of dysplasia but not of carcinoma in situ or invasive cancer and the effect was not significant for all cervical neoplasia combined. Use of condoms did not appear to affect the risk of cervical cancer.
In further analyses of all cervical neoplasia combined, we additionally adjusted ORs for each contraceptive method for use of all the other contraceptive methods and also for ever having had an induced abortion during follow-up (results not shown). This caused the relative risk estimate for ever users of OCs to increase slightly from 1.40 to 1.70 (95% CI 1.18-3.38), whereas that for ever use of an IUD reduced from 1.38 to 1.28 (95% CI 0.95-1.72) and was no longer statistically significant. Tubal (1.13-2.46)11
(1.00-1.96)*** aNumber of cases in each subcategory. bAdjusted for social class, age at first birth, smoking, ever use of diaphragm and ever use of condom. x2 = 19.9 (P< 0.001), tx2 = 3.4 (P = 0.07), :X2 = 11.0 (P < 0.001), **x2 =12.0 (P<0.001), ttX2 = 5.61 (P = 0.02), tTX2 = 6.62 (P = 0.01), ***X2 = 4.04 (P = 0.04). All other P-values were > 0.1. (WHO, 1985 (WHO, , 1993 Brinton et al., 1986 Brinton et al., , 1987 Parazzini et al., 1990) or carcinoma in situ (Irwin et al., 1988; Jones et al., 1990; Kjaer et al., 1993; Ye et al., 1995) . Some smaller studies have reported no significant findings for long-term or recent OC use in relation to invasive cancer (Peters et al., 1986; Ebeling et al., 1987; Irwin et al., 1988; Cuzick et al., 1989) or carcinoma in situ (Molina et al., 1988; Becker et al., 1994) , and it has been suggested that the previously reported results relating OC use to cervical neoplasia were caused by detection bias and lack of control for confounding (Irwin et al., 1988) . Two large case-control studies investigated the combined effect of duration and recency of OC use on risk of invasive carcinoma of the cervix WHO 1993) . In agreement with our results, these studies also reported the highest relative risks in current/recent, long-term users of OCs. Results concerning the association between OC use and the risk of dysplasia have been inconclusive (Negrini et al., 1990; De Vet et al., 1993) . Our results suggest that OC use may not be as strongly associated with risk of dysplasia as with risk of invasive carcinoma or carcinoma in situ.
In this study we also observed a reduced risk of cervical neoplasia associated with use of the diaphragm, female tubal sterilisation and vasectomy of the husband. Use of barrier methods has been reported consistently as a protective factor for cervical cancer in previous studies (Parazzini et al., 1989; Coker et al., 1992) . Unexpectedly, we found no effect of use of the condom. A likely explanation for this is that condom users relied on this contraceptive method for relatively short periods of time compared with diaphragm users, since none of the women relying on condoms were using this method at entry to the study. A protective effect of female tubal sterilisation and of vasectomy has also been reported previously Brown, 1979, 1981) . The possible effect of the latter method has been interpreted as being due to the removal of sperm basic proteins that have been suggested as playing a role in cervical carcinogenesis (Reid et al., 1978) .
The significantly increased risk of cervical neoplasia for ever users of IUDs that was most evident for invasive carcinoma (Table II) One limitation of our study was that we were unable to adjust for the potentially important confounding effects of number of sexual partners and age at first intercourse. We did adjust for the effect of age at first birth (which was strongly related to cervical neoplasia risk) which, in this cohort of women married for the most part in the 1960s or earlier, may have been closely related to age at first intercourse. Age at marriage, which might also be expected to be related to factors such as age at first intercourse and number of sexual partners, was not related to cervical cancer risk in this study after adjustment for age at first birth (Table I ). Data collected in 1977 for a small subset of women in the cohort (58 with cervical neoplasia and 139 matched controls) found that women who were IUD users or OC users at entry did not differ with respect to age at first intercourse or number of sexual partners, whereas diaphragm users at entry were less likely to have had intercourse at an early age and had had fewer sexual partners (Wright et al., 1978) . All women who entered the study were married, and the majority (69%) reported having had only one sexual partner. Strong confounding by number of sexual partners or age at first intercourse therefore seems unlikely in this study, although we cannot rule out the possibility that some residual confounding owing to these factors may have influenced the results.
Recently, infection with some subtypes of the human papillomavirus (16 and 18 in particular) has been strongly associated with risk of invasive cervical cancer in two casecontrol studies (Bosch et al., 1992; Eluf-Neto et al., 1994) . These studies, however, were conducted in settings where the prevalence of HPV infection of women was relatively high. Owing to very small numbers of HPV-negative cases and HPV-positive controls the independent effect of OC use on risk of cervical cancer could not be accurately determined. Risk of HPV infection is strongly associated with early age at first intercourse and in particular with the number of sexual partners (Eluf-Neto et al., 1994) . As mentioned earlier, the majority of the women in our study were likely to have had only one sexual partner and therefore the risk of HPV infection in these women may be relatively low. It should be noted, however, that we have no data at all on number of sexual partners of the husband that may have influenced the risk of HPV infection for the women in this study.
It was not possible to adjust our results for frequency of cervical cytological smearing since these data were available only during clinic follow-up. We were able, however, to investigate the potential confounding effect of this variable to some extent by examining the association between the average smear interval during clinic follow-up and use of oral and other methods of contraception using data for controls. Long-term users of OCs (over 72 months) had at least one clinic smear significantly more frequently than never or short-term users, but after adjusting for the period of follow-up in the clinic (which was relatively longer for longterm users of OCs) the statistical significance of this association disappeared. No differences were found across categories of time since last use of OCs, ever/never use of OCs and ever/never use of different methods of contraception at entry to the cohort. Although we cannot be sure that clinic smear frequency for controls was representative of the smear m 1297 frequency during the total follow-up period, these data provide some reassurance regarding the chance of a detection bias having occurred. Moreover, if a detection bias had been operating, and OC users had undergone cervical smearing more frequently than users of other methods, this would have tended to increase the chances of diagnosis of less severe lesions (Hulka, 1989 
